2016–2018
NSFC Young Scientists Fund 81500464
Led by Yu Shi, this project studied how myeloid-derived suppressor cells regulate monocyte and macrophage function in cirrhosis complicated by sepsis.
View sourcePrograms, guidance, and translation
A research record grounded in verifiable sources
2019–2022
NSFC General Program 81870425
Led by Yu Shi, this project investigated the origin, functional properties, and role of TREM-2-positive hepatic macrophages in liver failure.
View source2018–present
National Key R&D and Major Science Programs
The official hospital profile confirms participation as a task leader in two national programs and leadership of three NSFC grants. Public records do not yet support unambiguous titles and budgets for every task, so this site does not infer them.
View source2024
Guideline for Diagnosis and Treatment of Liver Failure (2024)
Yu Shi served on the expert group and as a drafting author for the updated definitions, classification, diagnosis, and treatment recommendations.
View source2025
ACLF Kyoto Consensus: Steps from Asia
As a co-author of this international consensus, Yu Shi contributed to aligning ACLF definitions, stratification, and research frameworks across Asia.
View source2018
Second Prize, Zhejiang Natural Science Award
The award recognized foundational research on viral-hepatitis mechanisms and outcome prediction; Yu Shi was the fourth listed contributor.
View source2021
Granted invention patent CN110655566B
Preparation and application of soluble Tim-3 recombinant and mutant proteins; owned by Zhejiang University, with Yu Shi as a co-inventor.
View source2023
Granted invention patent CN111783792B
A method and application for extracting salient texture features from ultrasound images; owned by Zhejiang University, with Yu Shi as a co-inventor.
View source